(NYSE: ELV) Elevance Health's forecast annual revenue growth rate of 6.8% is forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 6.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.39%.
Elevance Health's revenue in 2025 is $183,325,000,000.On average, 17 Wall Street analysts forecast ELV's revenue for 2025 to be $44,060,183,471,996, with the lowest ELV revenue forecast at $43,483,644,237,520, and the highest ELV revenue forecast at $44,961,663,203,800. On average, 17 Wall Street analysts forecast ELV's revenue for 2026 to be $47,160,424,163,006, with the lowest ELV revenue forecast at $45,264,596,315,480, and the highest ELV revenue forecast at $50,275,080,159,300.
In 2027, ELV is forecast to generate $50,532,581,663,808 in revenue, with the lowest revenue forecast at $49,121,367,717,860 and the highest revenue forecast at $52,217,704,710,851.